Organon (OGN) announced that it has acquired from Biogen (BIIB) regulatory and commercial rights in the U.S. for Tofidence, a biosimilar to ...

Chinese tech stocks in correction territory amid profit-taking, selloff. Musk’s SpaceX, Apple at loggerheads over satellite ...

A new sub-analysis of the SELECT trial data shows semaglutide 2.4 mg substantially reduces the burden of total cardiovascular ...

Eli Lilly reports 94% Lp(a) reduction with lepodisiran in Phase 2 trials, targeting inherited heart disease risk.

Tariffs will squeeze profits for Lululemon (LULU), the company’s chief financial officer has warned, after the company ...

Chinese automakers missed out on a European rebound in EV demand last month, as more-established manufacturers like ...